Free Trial

Waters Co. (NYSE:WAT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Waters logo with Medical background

Shares of Waters Co. (NYSE:WAT - Get Free Report) have received a consensus rating of "Moderate Buy" from the eighteen research firms that are presently covering the company, Marketbeat reports. Nine research analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $390.19.

WAT has been the subject of a number of analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a research report on Thursday, March 6th. Baird R W raised shares of Waters from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 26th. Bank of America decreased their price objective on shares of Waters from $430.00 to $410.00 and set a "neutral" rating for the company in a research report on Thursday, February 13th. Robert W. Baird upped their price objective on shares of Waters from $355.00 to $374.00 and gave the company an "outperform" rating in a research report on Wednesday, May 7th. Finally, Sanford C. Bernstein set a $400.00 price objective on shares of Waters and gave the company an "outperform" rating in a research report on Wednesday, April 16th.

View Our Latest Report on Waters

Institutional Investors Weigh In On Waters

Institutional investors and hedge funds have recently bought and sold shares of the business. Olde Wealth Management LLC acquired a new stake in Waters during the first quarter worth about $25,000. Aster Capital Management DIFC Ltd acquired a new stake in Waters during the fourth quarter worth about $28,000. Zions Bancorporation National Association UT acquired a new stake in Waters during the first quarter worth about $28,000. IFP Advisors Inc grew its position in Waters by 118.9% in the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Finally, Bank of Jackson Hole Trust bought a new position in Waters in the 4th quarter worth about $34,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Waters Stock Up 2.2%

Shares of Waters stock opened at $359.38 on Friday. The company has a fifty day moving average price of $346.71 and a 200 day moving average price of $370.88. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. Waters has a twelve month low of $279.24 and a twelve month high of $423.56. The stock has a market cap of $21.39 billion, a price-to-earnings ratio of 33.56, a price-to-earnings-growth ratio of 3.79 and a beta of 1.14.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $2.22 by $0.03. Waters had a net margin of 21.56% and a return on equity of 46.31%. The firm had revenue of $661.71 million during the quarter, compared to analysts' expectations of $655.50 million. During the same period in the prior year, the company earned $2.21 EPS. The firm's revenue was up 3.9% on a year-over-year basis. Equities research analysts forecast that Waters will post 12.86 earnings per share for the current fiscal year.

Waters Company Profile

(Get Free Report

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Analyst Recommendations for Waters (NYSE:WAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Waters Right Now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines